1-(benzo [D] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropanecarboxamide derivatives and related compounds as modulators of ATP-Binding Cassette transporters for the treatment of Cystic Fibrosis
Details for Australian Patent Application No. 2006336504 (hide)
International Classifications
Event Publications
31 July 2008 PCT application entered the National Phase
PCT publication WO2007/087066 Priority application(s): WO2007/087066
21 August 2008 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name Vertex Pharmaceuticals Incorporated, Application No. 2006336504, under INID (54), correct the title 1-(benzo [D] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropanecarboxamide derivatives and related compounds as modulators of ATP-Binding Cassette transporters for the treatment of Cystic Fibrosis
26 July 2012 Application Accepted
Published as AU-B-2006336504
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006336506-Inhibitors of tyrosine kinases and uses thereof
2006336496-System and method for requesting and issuing an authorization document
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser